Mark Lamotte
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 25
- Diabetes Management and Research 10
-
- Health Systems, Economic Evaluations, Quality of Life 18
- Pharmaceutical Economics and Policy 7
- Co-authors
- Lieven Annemans (25 shared papers)VOLKER FOOS (15 shared papers)Phil C. McEwan (14 shared papers)James L. Palmer (5 shared papers)Adam Lloyd (1 shared paper)David J.W. Grant (2 shared papers)Laetitia C. Gerlier (15 shared papers)Karen Moeremans (2 shared papers)
- Journals
- Value in Health (25 papers)Journal of Medical Economics (13 papers)Diabetes Therapy (6 papers)PharmacoEconomics (5 papers)Applied Health Economics and Health Policy (3 papers)
- Partner nations
- United KingdomBelgiumUnited States
In The Last Decade
Mark Lamotte
107 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 125
- Endocrinology, Diabetes and Metabolism 491
- Nephrology 85
- Cardiology and Cardiovascular Medicine 235
- Pediatrics, Perinatology and Child Health 142
- Pulmonary and Respiratory Medicine 230
Countries citing papers authored by Mark Lamotte
This map shows the geographic impact of Mark Lamotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lamotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lamotte more than expected).
Fields of papers citing papers by Mark Lamotte
This network shows the impact of papers produced by Mark Lamotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lamotte. The network helps show where Mark Lamotte may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lamotte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 196 | |
| 2 | 2002 | 121 | |
| 3 | 2004 | 77 | |
| 4 | 2018 | 67 | |
| 5 | 2003 | 60 | |
| 6 | 2019 | 50 | |
| 7 | 2002 | 47 | |
| 8 | 2010 | 39 | |
| 9 | 2014 | 37 | |
| 10 | 2018 | 36 | |
| 11 | 2008 | 36 | |
| 12 | 2020 | 36 | |
| 13 | 2004 | 32 | |
| 14 | 1997 | 32 | |
| 15 | 2019 | 31 | |
| 16 | 2003 | 29 | |
| 17 | 2018 | 28 | |
| 18 | 2006 | 27 | |
| 19 | 2006 | 26 | |
| 20 | 2017 | 25 |
About Mark Lamotte
Mark Lamotte is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics, Cardiology and Cardiovascular Medicine, Hematology and Surgery, having authored 115 papers that have together received 1.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (25 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers), Diabetes Management and Research (10 papers), Pharmaceutical Economics and Policy (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Lipoproteins and Cardiovascular Health (5 papers), Diabetes and associated disorders (4 papers) and Influenza Virus Research Studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (491 citations), Nephrology (85 citations), Cardiology and Cardiovascular Medicine (235 citations), Pediatrics, Perinatology and Child Health (142 citations) and Pulmonary and Respiratory Medicine (230 citations). Mark Lamotte has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include Lieven Annemans, VOLKER FOOS, Phil C. McEwan, James L. Palmer, Adam Lloyd, David J.W. Grant, Laetitia C. Gerlier, Karen Moeremans, An Uyttebroeck and Rob Pieters. Their work appears in journals such as Value in Health, Journal of Medical Economics, Diabetes Therapy, PharmacoEconomics and Applied Health Economics and Health Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.